Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
United States
Altman Clinical and Translational Research Institute, La Jolla, California University of California, San Diego, San Diego, California